140 related articles for article (PubMed ID: 17722972)
1. Adverse drug event detection in a community hospital utilising computerised medication and laboratory data.
Seger AC; Jha AK; Bates DW
Drug Saf; 2007; 30(9):817-24. PubMed ID: 17722972
[TBL] [Abstract][Full Text] [Related]
2. A computerized adverse drug event alerting system using clinical rules: a retrospective and prospective comparison with conventional medication surveillance in the Netherlands.
Rommers MK; Teepe-Twiss IM; Guchelaar HJ
Drug Saf; 2011 Mar; 34(3):233-42. PubMed ID: 21332247
[TBL] [Abstract][Full Text] [Related]
3. Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application.
Jha AK; Laguette J; Seger A; Bates DW
J Am Med Inform Assoc; 2008; 15(5):647-53. PubMed ID: 18579834
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of rule effectiveness and positive predictive value of clinical rules in a Dutch clinical decision support system in daily hospital pharmacy practice.
Rommers MK; Zwaveling J; Guchelaar HJ; Teepe-Twiss IM
Artif Intell Med; 2013 Sep; 59(1):15-21. PubMed ID: 23664455
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and consequences of drug allergy alert overrides in a computerized physician order entry system.
Hsieh TC; Kuperman GJ; Jaggi T; Hojnowski-Diaz P; Fiskio J; Williams DH; Bates DW; Gandhi TK
J Am Med Inform Assoc; 2004; 11(6):482-91. PubMed ID: 15298998
[TBL] [Abstract][Full Text] [Related]
6. Medication safety program reduces adverse drug events in a community hospital.
Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
[TBL] [Abstract][Full Text] [Related]
7. Physicians' decisions to override computerized drug alerts in primary care.
Weingart SN; Toth M; Sands DZ; Aronson MD; Davis RB; Phillips RS
Arch Intern Med; 2003 Nov; 163(21):2625-31. PubMed ID: 14638563
[TBL] [Abstract][Full Text] [Related]
8. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital.
Raschke RA; Gollihare B; Wunderlich TA; Guidry JR; Leibowitz AI; Peirce JC; Lemelson L; Heisler MA; Susong C
JAMA; 1998 Oct; 280(15):1317-20. PubMed ID: 9794309
[TBL] [Abstract][Full Text] [Related]
9. Impact of vendor computerized physician order entry in community hospitals.
Leung AA; Keohane C; Amato M; Simon SR; Coffey M; Kaufman N; Cadet B; Schiff G; Zimlichman E; Seger DL; Yoon C; Song P; Bates DW
J Gen Intern Med; 2012 Jul; 27(7):801-7. PubMed ID: 22271271
[TBL] [Abstract][Full Text] [Related]
10. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports.
Winterstein AG; Hatton RC; Gonzalez-Rothi R; Johns TE; Segal R
Am J Health Syst Pharm; 2002 Sep; 59(18):1742-9. PubMed ID: 12298112
[TBL] [Abstract][Full Text] [Related]
11. Development of a computerized adverse drug event monitor.
Evans RS; Pestotnik SL; Classen DC; Bass SB; Menlove RL; Gardner RM; Burke JP
Proc Annu Symp Comput Appl Med Care; 1991; ():23-7. PubMed ID: 1807594
[TBL] [Abstract][Full Text] [Related]
12. Computerized surveillance of adverse drug events in hospital patients.
Classen DC; Pestotnik SL; Evans RS; Burke JP
JAMA; 1991 Nov; 266(20):2847-51. PubMed ID: 1942452
[TBL] [Abstract][Full Text] [Related]
13. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.
Jha AK; Kuperman GJ; Teich JM; Leape L; Shea B; Rittenberg E; Burdick E; Seger DL; Vander Vliet M; Bates DW
J Am Med Inform Assoc; 1998; 5(3):305-14. PubMed ID: 9609500
[TBL] [Abstract][Full Text] [Related]
14. High rates of adverse drug events in a highly computerized hospital.
Nebeker JR; Hoffman JM; Weir CR; Bennett CL; Hurdle JF
Arch Intern Med; 2005 May; 165(10):1111-6. PubMed ID: 15911723
[TBL] [Abstract][Full Text] [Related]
15. Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools.
Wright A; Feblowitz J; Phansalkar S; Liu J; Wilcox A; Keohane CA; Seger DL; Bloomrosen M; Kuperman GJ; Bates DW
Am J Health Syst Pharm; 2012 Feb; 69(3):221-7. PubMed ID: 22261944
[TBL] [Abstract][Full Text] [Related]
16. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
[TBL] [Abstract][Full Text] [Related]
17. Outpatient adverse drug events identified by screening electronic health records.
Gandhi TK; Seger AC; Overhage JM; Murray MD; Hope C; Fiskio J; Teal E; Bates DW
J Patient Saf; 2010 Jun; 6(2):91-6. PubMed ID: 22130350
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a computer-based adverse-drug-event monitor.
Hwang SH; Lee S; Koo HK; Kim Y
Am J Health Syst Pharm; 2008 Dec; 65(23):2265-72. PubMed ID: 19020194
[TBL] [Abstract][Full Text] [Related]
19. A model for medication safety event detection.
Snyder RA; Fields W
Int J Qual Health Care; 2010 Jun; 22(3):179-86. PubMed ID: 20348558
[TBL] [Abstract][Full Text] [Related]
20. PSIP: an overview of the results and clinical implications.
Beuscart R
Stud Health Technol Inform; 2011; 166():3-12. PubMed ID: 21685604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
